European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Date of authorisation: 20/10/1995, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Date of authorisation: 20/10/1995, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Vyvgart, efgartigimod alfa, Date of authorisation: 10/08/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Vyvgart, efgartigimod alfa, Date of authorisation: 10/08/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 7, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2026, 10:00 (CEST) to 23 September 2026, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2026, 10:00 (CEST) to 23 September 2026, 12:00 (CEST)

11th EFIM Day

The 11th edition of the EFIM Day took place in Brussels on Friday, 16 October gathering representatives of EFIM National Societies, EFIM Executive Committee members, Working Group Chairs, Young Internists, and invited guests from across Europe for discussions on the future of Internal Medicine and the work of EFIM. A total of approximately 46 participants representing 26 national societies, EFIM Executive Committee, and invited speakers attended the meeting in Brussels.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.